Fibronostics

Fibronostics is engaged in the development of non-invasive diagnostic testing systems that utilize artificial intelligence for health monitoring. The company's technology focuses on the assessment of liver disease and its progression, as well as chronic conditions such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. By providing algorithm-based insights, Fibronostics enables healthcare professionals to detect early signs of these diseases, facilitating more effective monitoring and management of patient health.